fluconazole has been researched along with Black Fever in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have previously shown that 3-nitro-1H-1,2,4-triazole-based arylamides and arylsulfonamides demonstrate significant activity in vitro against Trypanosoma cruzi, the causative parasite of Chagas disease." | 3.80 | Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents. ( Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR, 2014) |
| " To combat this situation, leishmanicidal efficacy of already marketed standard antifungal drug, fluconazole under the approach of "therapeutic switching" in combination with standard antileishmanial drug, miltefosine, and a potent immunomodulator agent, picroliv, were evaluated in hamsters infected with Leishmania donovani." | 1.37 | Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv. ( Gupta, S; Sane, SA; Shakya, N, 2011) |
| "Standard treatments for visceral leishmaniasis (antimonials, amphotericin B and pentamidine) pose several problems." | 1.33 | Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure. ( Colakoglu, M; Colakoglu, NY; Yaylali, GF; Yilmaz, M, 2006) |
| "Standard treatments for visceral leishmaniasis (antimonials, amphotericin B and pentamidine) pose several problems." | 1.33 | Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure. ( Colakoglu, M; Fidan Yaylali, G; Yalcin Colakoglu, N; Yilmaz, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadopoulou, MV | 1 |
| Bloomer, WD | 1 |
| Rosenzweig, HS | 1 |
| Wilkinson, SR | 1 |
| Kaiser, M | 1 |
| Rybniker, J | 1 |
| Goede, V | 1 |
| Mertens, J | 1 |
| Ortmann, M | 1 |
| Kulas, W | 1 |
| Kochanek, M | 1 |
| Benzing, T | 1 |
| Arribas, JR | 1 |
| Fätkenheuer, G | 1 |
| Shakya, N | 1 |
| Sane, SA | 1 |
| Gupta, S | 1 |
| Colakoglu, M | 2 |
| Yaylali, GF | 1 |
| Colakoglu, NY | 1 |
| Yilmaz, M | 2 |
| Fidan Yaylali, G | 1 |
| Yalcin Colakoglu, N | 1 |
| Torrús, D | 1 |
| Boix, V | 1 |
| Massa, B | 1 |
| Portilla, J | 1 |
| Pérez-Mateo, M | 1 |
| Sundar, S | 2 |
| Singh, VP | 1 |
| Agrawal, NK | 1 |
| Gibbs, DL | 1 |
| Murray, HW | 1 |
| Kumar, P | 1 |
| Makharia, M | 1 |
| Goyal, A | 1 |
| Rogers, M | 1 |
| Gibbs, D | 1 |
| Murray, H | 1 |
| Jha, BB | 1 |
| Al-Abdely, HM | 1 |
| Graybill, JR | 1 |
| Loebenberg, D | 1 |
| Melby, PC | 1 |
1 review available for fluconazole and Black Fever
| Article | Year |
|---|---|
Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Com | 2010 |
2 trials available for fluconazole and Black Fever
| Article | Year |
|---|---|
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Child; Child, Presc | 1998 |
Fluconazole in visceral leishmaniasis.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; India; Leishman | 1998 |
7 other studies available for fluconazole and Black Fever
| Article | Year |
|---|---|
Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Topics: Amides; Apoptosis; Blood Platelets; Cells, Cultured; Chagas Disease; Flow Cytometry; Heterocyclic Co | 2014 |
Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Drug Therapy, Combination; Fluconazole; Glyco | 2011 |
Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
Topics: Allopurinol; Antifungal Agents; Antimetabolites; Diabetic Nephropathies; Fluconazole; Humans; Leishm | 2006 |
Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Diabetic Nephropathies; Drug Therapy, C | 2006 |
Fluconazole plus allopurinol in treatment of visceral leishmaniasis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Allopurinol; Antifungal Agents; Antimetabolites; Bone Mar | 1996 |
Treatment of kala-azar with oral fluconazole.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Drug Administration Schedule; Fema | 1996 |
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Topics: Amphotericin B; Animals; Fluconazole; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, | 1999 |